ALLO
Price
$1.42
Change
+$0.13 (+10.08%)
Updated
Jun 6 closing price
Capitalization
282.16M
60 days until earnings call
CRSP
Price
$41.86
Change
+$3.29 (+8.53%)
Updated
Jun 6 closing price
Capitalization
3.62B
65 days until earnings call
Interact to see
Advertisement

ALLO vs CRSP

Header iconALLO vs CRSP Comparison
Open Charts ALLO vs CRSPBanner chart's image
Allogene Therapeutics
Price$1.42
Change+$0.13 (+10.08%)
Volume$3.48M
Capitalization282.16M
CRISPR Therapeutics AG
Price$41.86
Change+$3.29 (+8.53%)
Volume$4.73M
Capitalization3.62B
ALLO vs CRSP Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. CRSP commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a StrongBuy and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ALLO: $1.42 vs. CRSP: $41.86)
Brand notoriety: ALLO and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 105% vs. CRSP: 213%
Market capitalization -- ALLO: $282.16M vs. CRSP: $3.62B
ALLO [@Biotechnology] is valued at $282.16M. CRSP’s [@Biotechnology] market capitalization is $3.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 3 bearish.
  • CRSP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than CRSP.

Price Growth

ALLO (@Biotechnology) experienced а +21.37% price change this week, while CRSP (@Biotechnology) price change was +15.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 06, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.62B) has a higher market cap than ALLO($282M). CRSP YTD gains are higher at: 6.352 vs. ALLO (-33.333). ALLO has higher annual earnings (EBITDA): -243.33M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. ALLO (292M). ALLO has less debt than CRSP: ALLO (90.8M) vs CRSP (219M). CRSP has higher revenues than ALLO: CRSP (35M) vs ALLO (22K).
ALLOCRSPALLO / CRSP
Capitalization282M3.62B8%
EBITDA-243.33M-455.24M53%
Gain YTD-33.3336.352-525%
P/E RatioN/AN/A-
Revenue22K35M0%
Total Cash292M1.86B16%
Total Debt90.8M219M41%
FUNDAMENTALS RATINGS
ALLO vs CRSP: Fundamental Ratings
ALLO
CRSP
OUTLOOK RATING
1..100
417
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
6561
P/E GROWTH RATING
1..100
10078
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (65) in the Biotechnology industry is in the same range as ALLO (97). This means that CRSP’s stock grew similarly to ALLO’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALLO (100). This means that CRSP’s stock grew similarly to ALLO’s over the last 12 months.

CRSP's SMR Rating (92) in the Biotechnology industry is in the same range as ALLO (94). This means that CRSP’s stock grew similarly to ALLO’s over the last 12 months.

CRSP's Price Growth Rating (61) in the Biotechnology industry is in the same range as ALLO (65). This means that CRSP’s stock grew similarly to ALLO’s over the last 12 months.

CRSP's P/E Growth Rating (78) in the Biotechnology industry is in the same range as ALLO (100). This means that CRSP’s stock grew similarly to ALLO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOCRSP
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEIGX11.22N/A
N/A
MassMutual Disciplined Gr Svc
LIMIX7.90N/A
N/A
Cromwell Tran Sustainable Focus Instl
MTRBX19.23N/A
N/A
MFS Total Return B
NWJCX105.10N/A
N/A
Nationwide NYSE Arca Tech 100 Idx A
MBVKX19.89N/A
N/A
BlackRock Large Cap Focus Value K

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+8.53%
RXRX - CRSP
73%
Closely correlated
+20.13%
BEAM - CRSP
72%
Closely correlated
+9.26%
NTLA - CRSP
66%
Loosely correlated
+6.73%
PRME - CRSP
64%
Loosely correlated
+24.26%
ABCL - CRSP
63%
Loosely correlated
+2.95%
More